- Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
-
Toshikuni
- KMID: 2412206
- Gut Liver.
- 2017 May;11(3):335-348.
- doi: 10.5009/gnl15458
Chronic hepatitis C virus (HCV) infection may eventually lead to liver cirrhosis (LC), a condition associated with a high risk of liver failure and hepatocellular carcinoma. Although interferon (IFN)-based therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Protein-Losing Enteropathy Induced by Intestinal Lymphangiectasia in a Liver Cirrhosis Patient with Octreotide: A Case Report
-
Lee HL, Han DS, Kim JB, Jeon YC, Sohn JH, Hahm JS
- KMID: 1786830
- J Korean Med Sci.
- 2004 Jun;19(3):466-469.
- doi: 10.3346/jkms.2004.19.3.466
A 47-yr-old man with hepatitis B virus associated liver cirrhosis was admitted to our hospital with diarrhea and generalized edema and diagnosed as protein-losing enteropathy due to intestinal lymphangiectasia by... -
- CITED
-
- Close
- SHARE
-
- Close
- Hope for Cirrhosis Patients with Genotype 1 Hepatitis C Virus Who Failed the Previous Treatment
-
Kwon JH
- KMID: 2373327
- Korean J Gastroenterol.
- 2015 Aug;66(2):131-133.
- doi: 10.4166/kjg.2015.66.2.131
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
-
Tamai H, Shingaki N, Mori Y, Moribata K, Kawashima , Maeda Y, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M
- KMID: 2412052
- Gut Liver.
- 2016 Jul;10(4):617-623.
- doi: 10.5009/gnl15193
BACKGROUND/AIMS: This study aimed to predict sustained viral response (SVR) to low-dose pegylated interferon (PEG-IFN) plus ribavirin of elderly and/or cirrhotic patients with genotype 2 hepatitis C virus (HCV) using... -
- CITED
-
- Close
- SHARE
-
- Close
